COmpliance and Efficacy in Mono and Combination Tablet Study ATacand/Atacand Plus

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2007
To evaluate compliance and patients\' satisfaction in mono and combination treatment of Candesartan cilexetil (Atacand)/ Candesartan cilexetil 16mg, hydrochlorothiazide 12.5mg (Atacand plus) in hypertension.
Epistemonikos ID: fd8374e7057fdfac338f725d17ff09b3ff66730f
First added on: May 04, 2024